Structure Therapeutics Inc. - ADR is a clinical-stage global biopharmaceutical company specialising in the discovery and development of transformative medicines used to treat the unmet medical needs of various diseases affecting the pulmonary, metabolic, and cardiovascular systems.
Its business operates within the biotechnology and pharmaceutical industries. By applying its structure-based drug discovery platform, Structure Therapeutics Inc. has a pipeline of differentiated treatments, including small-molecule medicines, that are designed to overcome the limitations of biologic therapies.
Stay up-to-date on the share price of GPCR by adding it to your eToro watchlist.